J&S Studies, Inc.

College Station, Texas 77845

1 studies enrolling now · 59 studies all time

What they study most

Acne, Acne Vulgaris, Actinic Keratoses, Actinic Keratosis, Alopecia, Alopecia, Androgenetic, Androgenetic Alopecia, Atopic Dermatitis, Atopic Dermatitis Eczema, Axillary Hyperhidrosis, Baldness, Central Abdominal Bulging

Studies at this site

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities — Recruiting now
Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis — Stopped early
Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis — Completed
The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo — Completed
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs) — Completed
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis — Completed
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) — Completed
A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis — Stopped early
A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis — Completed
A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis — Completed
Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome — Stopped early
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA) — Completed
Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis — Completed
Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris — Completed
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo — Completed
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis — Completed
Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis — Status unconfirmed
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA) — Completed
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris — Completed
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis — Completed
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris — Completed
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris — Completed
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of SUN13834 in Adult Subjects With Atopic Dermatitis — Completed
Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp — Completed
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp — Completed
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea — Completed
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% — Completed
Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris — Completed
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) — Completed
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis — Stopped early
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 — Completed
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test — Completed
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis — Completed
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis — Completed
Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis — Completed
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel — Completed
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis — Completed
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA) — Stopped early
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 — Completed
Twelve Month Follow-Up of CP0108 — Completed
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat — Completed
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris — Completed
Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities — Completed
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) — Completed
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies — Completed
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations — Completed
Phase 1 Safety and PK Study of OLT1177 Capsules — Completed